8th ImmunoTherapy of Cancer Conference

Contenuti (corsi)
The 8th Immunotherapy of Cancer Conference (ITOC8) to be held virtually from October 8 - 9, 2021 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.

Obiettivi didattici, obiettivi del training
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and del

Pubblico target
Immunology, Oncology, Drug Development, Vaccines, Tumour,

Certificazioni
A confirmation will be issued after the conference. The conferene will appply for CME accreditation.

Organizzatori regionali
ITOC8 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.

Please click here https://www.itoc-conference.eu/registration to view registration details

Ms. Catherine Tomek